Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Steven Abman to Persistent Fetal Circulation Syndrome

This is a "connection" page, showing publications Steven Abman has written about Persistent Fetal Circulation Syndrome.

 
Connection Strength
  
 
 
10.301
  
  1. Danhaive O, Galambos C, Lakshminrusimha S, Abman SH. Pulmonary Hypertension in Developmental Lung Diseases. Clin Perinatol. 2024 03; 51(1):217-235.
    View in: PubMed
    Score: 0.796
  2. Galambos C, Logan JW, Stankiewicz P, Szafranski P, Zalles C, Gonzales J, Nath S, Patel S, Abman SH. Histologic features and decreased lung FOXF1 gene expression in severe bronchopulmonary dysplasia without a genetic diagnosis of alveolar capillary dysplasia. Pediatr Pulmonol. 2023 10; 58(10):2746-2749.
    View in: PubMed
    Score: 0.770
  3. Abman SH. Pulmonary Hypertension: The Hidden Danger for Newborns. Neonatology. 2021; 118(2):211-217.
    View in: PubMed
    Score: 0.663
  4. Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021 03; 56(3):661-669.
    View in: PubMed
    Score: 0.654
  5. Lakshminrusimha S, Kinsella JP, Krishnan US, Van Meurs K, Edwards EM, Bhatt DR, Chandrasekharan P, Oei JL, Manja V, Ramanathan R, Abman SH. Just Say No to iNO in Preterms-Really? J Pediatr. 2020 03; 218:243-252.
    View in: PubMed
    Score: 0.601
  6. Dodson RB, Morgan MR, Galambos C, Hunter KS, Abman SH. Chronic intrauterine pulmonary hypertension increases main pulmonary artery stiffness and adventitial remodeling in fetal sheep. Am J Physiol Lung Cell Mol Physiol. 2014 Dec 01; 307(11):L822-8.
    View in: PubMed
    Score: 0.421
  7. Galambos C, Sims-Lucas S, Ali N, Gien J, Dishop MK, Abman SH. Intrapulmonary vascular shunt pathways in alveolar capillary dysplasia with misalignment of pulmonary veins. Thorax. 2015 Jan; 70(1):84-5.
    View in: PubMed
    Score: 0.414
  8. Gien J, Tseng N, Seedorf G, Roe G, Abman SH. Peroxisome proliferator activated receptor-?-Rho-kinase interactions contribute to vascular remodeling after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014 Feb; 306(3):L299-308.
    View in: PubMed
    Score: 0.398
  9. Galambos C, Sims-Lucas S, Abman SH. Histologic evidence of intrapulmonary anastomoses by three-dimensional reconstruction in severe bronchopulmonary dysplasia. Ann Am Thorac Soc. 2013 Oct; 10(5):474-81.
    View in: PubMed
    Score: 0.391
  10. Galambos C, Sims-Lucas S, Abman SH. Three-dimensional reconstruction identifies misaligned pulmonary veins as intrapulmonary shunt vessels in alveolar capillary dysplasia. J Pediatr. 2014 Jan; 164(1):192-5.
    View in: PubMed
    Score: 0.391
  11. Abman SH. Inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Handb Exp Pharmacol. 2013; 218:257-76.
    View in: PubMed
    Score: 0.372
  12. Gien J, Tseng N, Seedorf G, Roe G, Abman SH. Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res. 2013 Mar; 73(3):252-62.
    View in: PubMed
    Score: 0.369
  13. Chester M, Seedorf G, Tourneux P, Gien J, Tseng N, Grover T, Wright J, Stasch JP, Abman SH. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2011 Nov; 301(5):L755-64.
    View in: PubMed
    Score: 0.338
  14. Abman SH. Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol. 2010; 661:323-35.
    View in: PubMed
    Score: 0.302
  15. Grover TR, Parker TA, Abman SH. Vascular endothelial growth factor improves pulmonary vascular reactivity and structure in an experimental model of chronic pulmonary hypertension in fetal sheep. Chest. 2005 Dec; 128(6 Suppl):614S.
    View in: PubMed
    Score: 0.227
  16. Abman SH. Neonatal pulmonary hypertension: a physiologic approach to treatment. Pediatr Pulmonol Suppl. 2004; 26:127-8.
    View in: PubMed
    Score: 0.199
  17. Yildiz B?l?kbasi E, Karolak JA, Szafranski P, Gambin T, Willard N, Abman SH, Galambos C, Kinsella JP, Stankiewicz P. High-level gonosomal mosaicism for a pathogenic non-coding CNV deletion of the lung-specific FOXF1 enhancer in an unaffected mother of an infant with ACDMPV. Mol Genet Genomic Med. 2022 11; 10(11):e2062.
    View in: PubMed
    Score: 0.182
  18. Cookson MW, Abman SH, Kinsella JP, Mandell EW. Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension. Semin Fetal Neonatal Med. 2022 08; 27(4):101367.
    View in: PubMed
    Score: 0.178
  19. Abman SH. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev. 1999 Nov; 20(11):e103-9.
    View in: PubMed
    Score: 0.149
  20. Kinsella JP, Abman SH. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group. Chest. 1998 Jul; 114(1 Suppl):100S.
    View in: PubMed
    Score: 0.136
  21. Kinsella JP, Abman SH. Controversies in the use of inhaled nitric oxide therapy in the newborn. Clin Perinatol. 1998 Mar; 25(1):203-17.
    View in: PubMed
    Score: 0.133
  22. Kinsella JP, Abman SH. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn. Eur J Pediatr. 1998 Jan; 157 Suppl 1:S28-30.
    View in: PubMed
    Score: 0.131
  23. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997 Jul; 131(1 Pt 1):55-62.
    View in: PubMed
    Score: 0.127
  24. Abman SH, Ivy DD, Ziegler JW, Kinsella JP. Mechanisms of abnormal vasoreactivity in persistent pulmonary hypertension of the newborn infant. J Perinatol. 1996 Mar-Apr; 16(2 Pt 2 Su):S18-23.
    View in: PubMed
    Score: 0.116
  25. Kinsella JP, Abman SH. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy. J Perinatol. 1996 Mar-Apr; 16(2 Pt 2 Su):S24-7.
    View in: PubMed
    Score: 0.116
  26. Abman SH, Kinsella JP. Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: the physiology matters! Pediatrics. 1995 Dec; 96(6):1153-5.
    View in: PubMed
    Score: 0.114
  27. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Th?baud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24; 132(21):2037-99.
    View in: PubMed
    Score: 0.113
  28. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide. Lancet. 1995 Sep 02; 346(8975):647-8.
    View in: PubMed
    Score: 0.112
  29. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr. 1995 Jun; 126(6):853-64.
    View in: PubMed
    Score: 0.110
  30. Abman SH, Kinsella JP. Inhaled nitric oxide therapy of pulmonary hypertension and respiratory failure in premature and term neonates. Adv Pharmacol. 1995; 34:457-74.
    View in: PubMed
    Score: 0.107
  31. Abman SH. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr Opin Pediatr. 1994 Jun; 6(3):239-47.
    View in: PubMed
    Score: 0.102
  32. Kinsella JP, Abman SH. Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn. Chest. 1994 Mar; 105(3 Suppl):92S-94S.
    View in: PubMed
    Score: 0.101
  33. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics. 1993 Oct; 92(4):606-9.
    View in: PubMed
    Score: 0.098
  34. Kinsella JP, Abman SH. Methaemoglobin during nitric oxide therapy with high-frequency ventilation. Lancet. 1993 Sep 04; 342(8871):615.
    View in: PubMed
    Score: 0.097
  35. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993 Jul; 123(1):103-8.
    View in: PubMed
    Score: 0.096
  36. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr. 1993 Jul; 123(1):109-14.
    View in: PubMed
    Score: 0.096
  37. Kinsella JP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics. 1993 May; 91(5):997-8.
    View in: PubMed
    Score: 0.095
  38. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 03; 340(8823):819-20.
    View in: PubMed
    Score: 0.091
  39. Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J Pediatr. 2007 Sep; 151(3):322-4.
    View in: PubMed
    Score: 0.064
  40. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. Semin Perinatol. 2005 Apr; 29(2):123-8.
    View in: PubMed
    Score: 0.054
  41. Holcomb RG, Tyson RW, Ivy DD, Abman SH, Kinsella JP. Congenital pulmonary venous stenosis presenting as persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 1999 Oct; 28(4):301-6.
    View in: PubMed
    Score: 0.037
  42. Abman SH, Kinsella JP. Inhaled nitric oxide therapy for pulmonary disease in pediatrics. Curr Opin Pediatr. 1998 Jun; 10(3):236-42.
    View in: PubMed
    Score: 0.034
  43. Kennaugh JM, Kinsella JP, Abman SH, Hernandez JA, Moreland SG, Rosenberg AA. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol. 1997 Sep-Oct; 17(5):366-9.
    View in: PubMed
    Score: 0.032
  44. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, Kinsella JP. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr. 1997 Jul; 131(1 Pt 1):70-5.
    View in: PubMed
    Score: 0.032
  45. Villamor E, Le Cras TD, Horan MP, Halbower AC, Tuder RM, Abman SH. Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am J Physiol. 1997 May; 272(5 Pt 1):L1013-20.
    View in: PubMed
    Score: 0.031
  46. Cornfield DN, Abman SH. Inhalational nitric oxide in pulmonary parenchymal and vascular disease. J Lab Clin Med. 1996 Jun; 127(6):530-9.
    View in: PubMed
    Score: 0.029
  47. Rosenberg AA, Kinsella JP, Abman SH. Cerebral hemodynamics and distribution of left ventricular output during inhalation of nitric oxide. Crit Care Med. 1995 Aug; 23(8):1391-7.
    View in: PubMed
    Score: 0.028
  48. Ziegler JW, Ivy DD, Kinsella JP, Abman SH. The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol. 1995 Jun; 22(2):387-403.
    View in: PubMed
    Score: 0.027
  49. Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J. Endothelin-1 decreases endothelial PPAR? signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15; 306(4):L361-71.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)